Flash Playerがインストールされていないか、バージョンが古い為、再生できません。
下記より最新のFlash Player(無償)をインストールし、再度アクセスしてください。
The webcast cannot be played, either because you have not installed
Flash Player or because you have an old version.
Please install the latest version of Flash Player (free) and access once again.
Flash Playerがインストールできない場合には、Windows Media Player版のサイトをご利用ください。
If you cannnot install Flash Player, please use the Windows Media Player site.
CMIC HOLDINGS Co., Ltd.
Overview of Financial Results for FY2019
November 14, 2019
Overview of Financial Results for FY2019
FY19 Financial highlights (October 1, 2018-September 30, 2019)
Wataru Mochizuki, CFO
CMIC Overview
CMIC's unique business model (PVC)
Comprehensively support the value chains of pharmaceutical companies
CMIC Group Global Coverage
Business segments and group companies
Main initiatives of the current term
Consolidated income statement (overview)
Breakdown of Non-operating income and expenses / Extraordinary income and losses / Income taxes
Sales & Operating income by segment
Orders received / Backlog
Trend in consolidated Sales & Operating income
Contract Research Organization (CRO) Business
Contract Development Manufacturing Organization (CDMO) Business
Contract Sales Organization (CSO) Business
Healthcare Business
Innovative Pharma Model( IPM )Business
Balance sheet (assets)
Balance sheet (liabilities and net assets)
Cash Flows
Forecast for FY ending Sep. 2020
Forecast for FY ending Sep. 2020
Forecast for FY ending Sep. 2020 (by segment)
Mid-term Management Plan (FY19-21) Progress Updates
Keiko Oishi, COO
Mid-term Plan (FY19-21) (Announced in November 2018)
Acceleration of PVC model and IPM solutions
Promotion of PVC projects
Understanding the CRO landscape
CRO business activities
CDMO business activities and CMIC Group Manufacturing Sites
CSO business activities
Healthcare business initiatives
To accelerate healthcare business transformation
IPM business activities
Promoting CRO Globalization
JAPAN Operations
Outside JAPAN Operations
Mid-term Management Plan Updates
Healthcare Revolution
Kazuo Nakamura, CEO
“Japanese paradox” and their longevity
Japan’s Mean Life Expectancy:From the bottom to the top
G7 Countries Median Life Expectancy(2050)
From CRO through PVC to Healthcare Value Creator
The CMIC Way
Actions required for CRO
The CMIC Way
Definition of the new healthcare system
SelCheck®
SelCheck®
SelCheck®
“harmo” business
Value of harmo service
Future outlook
Concept of using harmo as PHR
Joint research to improve Wellbeing
CMIC’S CREED
CMIC’S CREED